CEFOTAXIME PANPHARMA 0.5 g, powder for solution for injection (IM-IV) CIP 3400955083108
Active ingredients: Cefotaxime, Cefotaxime sodium
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injectionCIP 3400955083108intramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CEFOTAXIME PANPHARMA 0,5 g, poudre pour solution injectable (IM-IV)
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 0,5 g en flacon(s) en verre de 15 ml , boîte de 10
- Marketing authorisation holder
- PANPHARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Sept 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62501705CIP75508310CIP133400955083108Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉFOTAXIME SODIQUEpoudre | — | SA |
| CÉFOTAXIME BASEpoudre | 0,5 g · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.